These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35841401)

  • 1. Imaging for risk stratification of sudden cardiac death.
    van der Bijl P; Bax JJ
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):261-267. PubMed ID: 35841401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging for sudden cardiac death risk stratification: Current perspective and future directions.
    van der Bijl P; Delgado V; Bax JJ
    Prog Cardiovasc Dis; 2019; 62(3):205-211. PubMed ID: 31054859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres N; Hindricks G
    Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.
    Pour-Ghaz I; Heckle M; Ifedili I; Kayali S; Nance C; Kabra R; Jha SK; Jefferies JL; Levine YC
    Curr Cardiol Rev; 2022; 18(2):e040821195265. PubMed ID: 34348632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
    Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
    Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance imaging and primary prevention implantable cardioverter defibrillator therapy: current recommendations and future directions.
    Guaricci AI; De Santis D; Rabbat MG; Pontone G
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):223-228. PubMed ID: 29561311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools for risk stratification of sudden cardiac death: a review of the literature in different patient populations.
    Ragupathi L; Pavri BB
    Indian Heart J; 2014; 66 Suppl 1(Suppl 1):S71-81. PubMed ID: 24568833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
    Saba S
    Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging for assessment of sudden death risk: current role and future prospects.
    Suzuki T; Nazarian S; Jerosch-Herold M; Chugh SS
    Europace; 2016 Oct; 18(10):1491-1500. PubMed ID: 27098112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death risk markers for patients with left ventricular ejection fractions greater than 40.
    Halliday BP; Lota AS; Prasad SK
    Trends Cardiovasc Med; 2018 Nov; 28(8):516-521. PubMed ID: 29907466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy and sudden cardiac death.
    Giamouzis G; Dimos A; Xanthopoulos A; Skoularigis J; Triposkiadis F
    Heart Fail Rev; 2022 Mar; 27(2):711-724. PubMed ID: 34184173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.